Intrathecal administration of recombinant human hepatocyte growth factor for acute spinal cord injury: the road from bench to clinical trial and future perspective
Kitamura, K.; Iwanami, A.; Okano, H.; Toyama, Y.; Nakamura, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 5): 463-467
2015
ISSN/ISBN: 0047-1852 PMID: 30458098 Document Number: 679056
Document emailed within 1 workday
Related Documents
Bracken, M.B.; Shepard, M.J.; Holford, T.R.; Leo-Summers, L.; Aldrich, E.F.; Fazl, M.; Fehlings, M.; Herr, D.L.; Hitchon, P.W.; Marshall, L.F.; Nockels, R.P.; Pascale, V.; Perot, P.L.; Piepmeier, J.; Sonntag, V.K.; Wagner, F.; Wilberger, J.E.; Winn, H.R.; Young, W. 1997: Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study JAMA 277(20): 1597-1604Isu, T. 1990: Spinal cord evoked potential in experimental spinal cord injury--the changes in spinal cord evoked potential following impact injury, and effect of mannitol administration on acute experimental spinal cord injury Hokkaido Journal of Medical Science 65(2): 142-151
Isu, T.; Iwasaki, Y.; Akino, M.; Abe, H. 1990: Effect of mannitol administration and myelotomy on acute experimental spinal cord injury: investigation by spinal cord evoked potential No Shinkei Geka. Neurological Surgery 18(3): 267-272
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Nishio, Y.; Sinatra, R.S.; Kitahata, L.M.; Collins, J.G. 1989: Spinal cord distribution of 3H-morphine after intrathecal administration: relationship to analgesia Anesthesia and Analgesia 69(3): 323-327
Broxmeyer, H.E.; Cooper, S.; Williams, D.E.; Hangoc, G.; Gutterman, J.U.; Vadhan-Raj, S. 1988: Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase i clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor Experimental Hematology 16(7): 594-602
Takano, K.; Hizuka, N.; Shizume, K.; Asakawa, K.; Fukuda, I.; Demura, H. 1991: Repeated sc administration of recombinant human insulin-like growth factor i (IGF-I) to human subjects for 7 days Growth Regulation 1(1): 23-28
Wang, W.; Yang, T.; Liu, L.; Pei, F. 2014: Proteomics study on effect of basic fibroblast growth factor long circulation liposome on spinal cord traction injury in rats Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 28(11): 1397-1405
Wehling, P.; Pak, M.A.; Georgescu, H.I. 1990: Intrathecal injection of a specific enzyme in rats as a model for chemically induced spinal cord injury Acta Orthopaedica Belgica 56(3-4): 539-544
Wang, Z.; Gerhard, L. 1995: Reexpression of nerve growth factor receptor in human traumatic injured spinal cord Chinese Medical Journal 108(6): 438-443
Wang, Y.; Lu, G.; Li, L.; Han, Z.; Yang, M.; Huang, T. 2005: Effects of neural stem cells transplantation on glial cell line-derived neurotrophic factor and growth associated protein 43 after spinal cord injury in rats Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 19(6): 416-419
Yoshioka, T.; Morimoto, Y.; Iwagaki, H.; Itoh, H.; Saito, S.; Kobayashi, N.; Yagi, T.; Tanaka, N. 2001: Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells Journal of International Medical Research 29(5): 409-420
Rivlin, A.S.; Tator, C.H. 1978: Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat Surgical Neurology 10(1): 38-43
Abbruzzese, J.L.; Levin, B.; Ajani, J.A.; Faintuch, J.S.; Saks, S.; Patt, Y.Z.; Edwards, C.; Ende, K.; Gutterman, J.U. 1989: Phase i trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer Cancer Research 49(14): 4057-4061
Kato, M. 1998: Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes Hokkaido Journal of Medical Science 73(6): 613-625
Nakamura, M.; Toyama, Y.; Okano, H. 2013: Current status and perspective on regenerative medicine for spinal cord injury using iPS cell Rinsho Shinkeigaku 53(11): 1013-1015
Bobinac, M.; Ćelić, T.; Vukelić, I.; Španjol, J.; Rubinić, N.; Bobinac, D. 2018: Nuclear factor erythroid 2-related factor 2 and choline acetyltransferase co-expression in rat spinal cord neurons after ischemia-reperfusion injury Journal of Biological Regulators and Homeostatic Agents 32(4): 803-813
Ishibashi, K.; Sasaki, S.; Sakamoto, H.; Hoshino, Y.; Nakamura, T.; Marumo, F. 1992: Expressions of receptor gene for hepatocyte growth factor in kidney after unilateral nephrectomy and renal injury Biochemical and Biophysical Research Communications 187(3): 1454-1459
Armstrong, T.A. 1993: In-flight administration of methylprednisolone to patients with spinal cord injury American Journal of Hospital Pharmacy 50(10): 2058
Ridgway, H.K.; Mellonig, J.T.; Cochran, D.L. 2008: Human histologic and clinical evaluation of recombinant human platelet-derived growth factor and beta-tricalcium phosphate for the treatment of periodontal intraosseous defects International Journal of Periodontics and Restorative Dentistry 28(2): 171-179